Strengthening Families & Communities LLC Increases Stock Position in CVS Health Corporation $CVS

Strengthening Families & Communities LLC raised its position in CVS Health Corporation (NYSE:CVS) by 1,923.9% in the third quarter, Holdings Channel reports. The institutional investor owned 31,654 shares of the pharmacy operator’s stock after purchasing an additional 30,090 shares during the period. Strengthening Families & Communities LLC’s holdings in CVS Health were worth $2,371,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of CVS. Norges Bank purchased a new stake in shares of CVS Health in the second quarter valued at approximately $1,358,698,000. Invesco Ltd. grew its stake in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after acquiring an additional 3,118,626 shares during the period. Jennison Associates LLC increased its holdings in CVS Health by 111.7% in the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after acquiring an additional 2,117,798 shares in the last quarter. Vanguard Group Inc. raised its position in CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after acquiring an additional 2,063,737 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in CVS Health by 153.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock valued at $214,240,000 after purchasing an additional 1,878,217 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CVS shares. Robert W. Baird boosted their target price on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Argus lowered their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Finally, JPMorgan Chase & Co. increased their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Trading Up 1.2%

Shares of CVS opened at $75.43 on Tuesday. CVS Health Corporation has a 12-month low of $53.36 and a 12-month high of $85.15. The firm has a market capitalization of $95.76 billion, a P/E ratio of 198.51, a P/E/G ratio of 0.69 and a beta of 0.50. The firm has a 50-day moving average price of $78.85 and a 200 day moving average price of $75.33. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. CVS Health’s dividend payout ratio is currently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.